Emery Pharma

Emery Pharma is a full-service contract research organization (CRO) supporting end-to-end development of small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more.

Services

Analytical Services: Method development and validation for quantitation and characterization of compounds; impurity analysis including residual solvents, process-related impurities, nitrosamine testing, extractables/leachables, and degradant issues.

Bioanalytical Services: Central lab support for clinical studies and preclinical packages with robust and sensitive methods for analyte analysis in challenging physiological matrices.

Biologics Characterization: Structural and chemical characterization of biologic compounds.

Cell & Microbiology Services: Microbiological characterization with hundreds of bacterial strains including multidrug-resistant clinical isolates, ESKAPE pathogens, and fungal strains.

Botanical Drug Development: Expertise spanning conception through discovery R&D, IND submission, and clinical trials.

Consulting & Litigation Support: Scientific analysis and expert testimony services.

Infrastructure

State-of-the-art instrumentation includes high-resolution mass spectrometry (Orbitrap), Triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR. Dedicated Quality Assurance department ensures quality, safety, and performance standards.